Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis.

Brain Pathology
Inderjit Singh, Aurora Pujol

Abstract

X-adrenoleukodystrophy (X-ALD) is a complex disease where inactivation of ABCD1 gene results in clinically diverse phenotypes, the fatal disorder of cerebral ALD (cALD) or a milder disorder of adrenomyeloneuropathy (AMN). Loss of ABCD1 function results in defective beta oxidation of very long chain fatty acids (VLCFA) resulting in excessive accumulation of VLCFA, the biochemical "hall mark" of X-ALD. At present, the ABCD1-mediated mechanisms that determine the different phenotype of X-ALD are not well understood. The studies reviewed here suggest for a "three-hit hypothesis" for neuropathology of cALD. An improved understanding of the molecular mechanisms associated with these three phases of cALD disease should facilitate the development of effective pharmacological therapeutics for X-ALD.

References

Jul 1, 1976·Journal of Neurochemistry·M GarashiK Suzuki
Nov 1, 1992·Journal of Neuropathology and Experimental Neurology·J M PowersH W Moser
Sep 1, 1995·Journal of Neuroimmunology·M C McGuinnessK D Smith
Jun 20, 1995·Proceedings of the National Academy of Sciences of the United States of America·N ShaniD Valle
Jul 1, 1993·Journal of Neurochemistry·R Wilson, J R Sargent
May 1, 1997·Journal of Neurochemistry·K DobashiI Singh
May 17, 1997·Biochimica Et Biophysica Acta·H Hayashi, A Sato
Aug 19, 1997·Proceedings of the National Academy of Sciences of the United States of America·J F LuK D Smith
Jan 7, 1998·Journal of Neuroscience Research·S Forss-PetterK A Nave
Feb 11, 1999·Neurochemical Research·A B MoserH W Moser
Mar 24, 1999·Trends in Neurosciences·M Dubois-DalcqP Aubourg
Feb 3, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M A ContrerasA K Singh
Jan 4, 2001·Journal of Neuropathology and Experimental Neurology·A G GilgI Singh
May 31, 2001·Journal of Neuropathology and Experimental Neurology·J M PowersH W Moser
Jul 12, 2003·Molecular Genetics and Metabolism·Fredoen ValianpourStephan Kemp
Jan 21, 2004·Biochimica Et Biophysica Acta·C R VargasC F Mello
Jan 14, 2005·Acta Neuropathologica·James M Powers
Dec 2, 2005·Journal of Neuropathology and Experimental Neurology·James M PowersKirby D Smith
Jun 6, 2006·Journal of the Neurological Sciences·Marion DeonCarmen R Vargas
Jun 8, 2006·Annual Review of Biochemistry·Ronald J A Wanders, Hans R Waterham
Jul 24, 2007·Nature Genetics·Celia M KassmannKlaus-Armin Nave
Mar 15, 2008·The Journal of Clinical Investigation·Alexandre S BassoHoward L Weiner
Mar 18, 2008·Human Molecular Genetics·Stéphane FourcadeAurora Pujol
May 9, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Craig Press, Jeffrey Milbrandt
Jun 11, 2008·Journal of Neurochemistry·Mushfiquddin KhanInderjit Singh
Jun 24, 2008·Annals of Neurology·Florian S EichlerRichard M Ransohoff
Sep 2, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Carlo W T van RoermundRonald J A Wanders

❮ Previous
Next ❯

Citations

Mar 13, 2014·Neurochemistry International·Denis I Crane
Apr 2, 2014·Pediatric Neurology·Panagiota TriantafyllouDimitrios I Zafeiriou
Dec 20, 2012·Brain : a Journal of Neurology·Jone López-ErauskinAurora Pujol
Nov 19, 2011·Human Molecular Genetics·Agatha SchlüterAurora Pujol
Jul 16, 2010·Brain Pathology·Johannes BergerSonja Forss-Petter
Jan 17, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yi GongFlorian S Eichler
Jun 2, 2016·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Fakhri KallabiHassen Kamoun
Jan 10, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Fatima-Ezzahra SaihMustapha Cherkaoui-Malki
Feb 23, 2011·Arquivos brasileiros de endocrinologia e metabologia·Fernanda Caroline SoardiMaricilda Palandi de Mello
Oct 6, 2015·Child Neurology Open·Ron JacobNaim Shehadeh
Jul 30, 2017·Journal of Clinical Medicine·Karolina M StepienIain P Hargreaves
Jan 30, 2018·Annals of the New York Academy of Sciences·Olga MatveevaMarkus Kleinewietfeld
Jan 1, 2015·Acta Neuropathologica·Nathalie LaunayAurora Pujol
Jan 8, 2013·Médecine sciences : M/S·Flore GeillonStéphane Savary
Dec 13, 2019·Expert Review of Neurotherapeutics·Mahmoud Reza AshrafiAli Reza Tavasoli
Nov 30, 2019·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Bela R TurkAnn B Moser
Jan 8, 2020·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Bela R TurkAnn B Moser
Jan 6, 2012·Journal of Neurology·Rebecca Deering BroseKirby D Smith
Jul 15, 2015·Cellular and Molecular Neurobiology·Marion DeonCarmen Vargas
Mar 8, 2011·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Edmond KahnGérard Lizard
Jun 25, 2013·Brain : a Journal of Neurology·Laia MoratóAurora Pujol
May 12, 2019·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Carlos CasasnovasAurora Pujol
Jul 24, 2015·Brain Pathology·Stephanie De MunterMyriam Baes
May 3, 2014·Metabolic Brain Disease·Asude DurmazFerda Özkınay
Jan 3, 2021·Pediatrics in Review·Lawrence ChangSiddharth Srivastava
Feb 21, 2021·Pain and Therapy·Valeria BachioccoAnna M Aloisi
Feb 5, 2014·Biochemical and Biophysical Research Communications·Jaspreet Singh, Shailendra Giri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenoleukodystrophy

Adrenoleukodystrophy (ALD), the most frequent peroxisomal disorder, is an X-linked disorder caused by a defect in the metabolism of long chain fatty acids leading to demyelination, neurodegeneration, and death. Here is the latest research.